Morgan Stanley Genetron Holdings LTD Transaction History

Morgan Stanley

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.91 - $1.23 $4,042 - $5,463	-4,442 Reduced 73.84%	1,574 $1,000
Q4 2022 Feb 14, 2023	SELL	$0.8 - $1.12 $657 - $920	-822 Reduced 12.02%	6,016 $6,000
Q3 2022 Nov 14, 2022	SELL	$0.91 - $1.69 $99,107 - $184,056	-108,909 Reduced 94.09%	6,838 $5,000
Q2 2022 Oct 27, 2022	BUY	$1.28 - $2.4 $3,609 - $6,768	2,820 Added 2.5%	115,747 $197,000
Q2 2022 Aug 15, 2022	BUY	$1.28 - $2.4 $3,609 - $6,768	2,820 Added 2.5%	115,747 $197,000
Q1 2022 Oct 27, 2022	SELL	$2.19 - $6.09 $6,175 - $17,173	-2,820 Reduced 2.44%	112,927 $247,000
Q1 2022 May 13, 2022	SELL	$2.19 - $6.09 $509,069 - $1.42 Million	-232,452 Reduced 67.3%	112,927 $247,000
Q4 2021 Feb 14, 2022	SELL	$5.81 - $14.39 $116,908 - $289,555	-20,122 Reduced 5.51%	345,379 $2.11 Million
Q3 2021 Nov 15, 2021	BUY	$11.55 - $20.3 $4.22 Million - $7.42 Million	365,501 New	365,501 $5.06 Million

7.5K

Ticker GTH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 90,602,304
Description
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.